压力和失眠不但会增加你的体重，还会加大你患心脏病，糖尿病，癌症，关节炎等其他疾病的风险。
Not only is it demoralizing to carry more weight than your ideal, it increases your risk of developing heart disease, diabetes, cancer, and arthritis, among other conditions.
这项在欧洲九个国家开展的调查表明，体重增加对于收入的消极影响在西班牙、希腊、意大利和葡萄牙等几个"油带"国家更为明显。
Research from nine European countries shows the negative impact of weight on wages is stronger in the "oil belt" nations which include Spain, Greece, Italy and Portugal.
[劳拉·范肯等，《夜间灯光通过改变进食时间增加体重》]
[Laura Fonken et al, Light at night increases body mass by shifting the time of food intake]
睡眠中断和不足能够引起从体重增加到心脏病等所有问题。
Disrupted and insufficient sleep has been linked to everything from weight gain to heart problems.
试验目的：新诊断2型糖尿病患者中，早期胰岛素治疗因为体重增加，低血糖发生，对于依从性下降以及生活质量下降的恐惧等因素而不被接受。
OBJECTIVE Early use of insulin after diagnosis of type 2 diabetes is met with resistance because of associated weight gain, hypoglycemia, and fear of decreased compliance and quality of life (QoL).
增加骨盐量的运动之一是移动体重的运动，相当于步行、跑、跳、舞蹈和滑雪等运动。
Bone mineral content can be increased by both exercise of moving body weight and resist exercise of strength training.
补充营养素，卧床休息，氧疗以及应用阿斯匹林、舒喘宁等药物可能会增加胎儿体重。
Nutrients supplication, bedrest and application of oxygen, aspirin, salbutamol etc. would increase fetal weight.
结论维吾尔族igh期CHD危险因素主要是胰岛素抵抗及由此产生的高胰岛素血症，可通过减轻体重、控制饮食、增加运动等改善。
Conclusion: insulin resistance including hyperinsulinemia is a major CHD risk factor in Uygur nationality with igh. They will require diet therapy and weight reduction.
结果：齐拉西酮有效率为86.7％，无明显增加体重，有直立性低血压、头晕、嗜睡等不良反应。
Results: ziprasidone efficient, without obvious for 86.7% weight, orthostatic hypotension, dizziness, sleepiness and so on adverse reactions.
但问题是这类药物并非没有副作用的，应用这类药物可能会发生水肿，体重增加及骨折风险等副作用。
My problem with that is that these medications are not without side effects, with edema, weight gain, and risk for fractures.
而磺脲类药物及胰岛素等均会引起体重增加。
As opposed to sulfonylurea, biguanides or insulin all of which promote weight gain.
甚至在控制了两组的一些诸如体育活动和卡路里消耗等因素后，睡眠时间和体重增加的关系保持。
The associations between sleep duration and weight gain persisted even after controlling for factors such as physical activity and calorie consumption in both groups.
所有患者均未出现肝肾功能变化、体重增加、色素沉着、低血压等不良反应。
Hepatorenal function change, weight gain, pigmentation, hypotension and other adverse reactions did not happen in patients.
所有患者均未出现肝肾功能变化、体重增加、色素沉着、低血压等不良反应。
Hepatorenal function change, weight gain, pigmentation, hypotension and other adverse reactions did not happen in patients.
应用推荐